662 search results for ‘*’
10/17/2017 | James Costello
A collaborative challenge aims to address the problem of medication adherence by predicting adverse treatment events.
10/12/2017 | Maria Montes-Bayón
We talk to Maria Montes-Bayón about mentors and the role of mass spectrometry in the field of human health.
10/12/2017 | Roisin McGuigan
If prospective registration is enforced for clinical trials, questionable results become easier to spot
10/12/2017 | Joanna Cummings
This year's Humanity in Science Award has been awarded to a scientist tackling fake pharmaceuticals
09/27/2017 | Werner Cautreels
Solutions are needed to teach the immune system to recognize biological drugs as partners, not plunderers.
09/27/2017 | Michael Schubert
An inexpensive, smartphone-based device could offer a wide range of point-of-care tests.
09/27/2017 | Roisin McGuigan
When you crunch the numbers on drug development, are the costs of cancer drugs justified?
09/19/2017 | Joanna Cummings
When it comes to identifying cancerous tissue, is the “MasSpec Pen” mightier than the sword?
09/19/2017 | James Strachan
Improving cancer drugs by “manufacturing” therapeutic compounds using gold nanoparticle catalysts.
Metal speciation in cerebrospinal fluid may bring new understanding of neurodegenerative diseases.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
You will benefit from:
Register
Express Insight into Bladder Cancer
Changing the Leopard’s Spots
Making It (Im)personal